|The TAC1 tac1 (Catalog #MBS6009007) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The TAC1, CT (TAC1, NKA, NKNA, TAC2, Protachykinin-1, PPT, Substance P, Neurokinin A, Neuromedin L, Substance K, Neuropeptide K, Neuropeptide gamma, C-terminal-flanking peptide) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s TAC1 can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB), Flow Cytometry (FC/FACS).
Suitable for use in Western Blot, Flow Cytometry, ELISA
Dilution: ELISA: 1:1,000
Western Blot: 1:100-500
Flow Cytometry: 1:10-50. Researchers should empirically determine the suitability of the TAC1 tac1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The TAC1 tac1 product has the following accession number(s) (GI #49456421) (NCBI Accession #CAG46531.1) (Uniprot Accession #P20366). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
TAC1, CT (TAC1, NKA, NKNA, TAC2, Protachykinin-1, PPT, Substance P, Neurokinin A, Neuromedin L, Substance K, Neuropeptide K, Neuropeptide gamma, C-terminal-flanking peptide)
Immunogen: TAC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 109-137 amino acids from the C-terminal region of human TAC1. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing TAC1 are readily searchable from our website. Different antibodies against the same target such as TAC1 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. The following patways have been known to be associated with this gene. TAC1 also interacts with the following gene(s): NTS, TAC3, TACR1, TACR2, TACR3. Brain, Embryonic Tissue, Eye, Nerve, Uncharacterized Tissue tissues are correlated with this protein. Bipolar Disorder, Disease Models, Animal, Edema, Hyperalgesia, Inflammation, Necrosis, Nervous System Diseases, Neurogenic Inflammation, Pain, Schizophrenia are some of the diseases may be linked to TAC1, CT (TAC1, NKA, NKNA, TAC2, Protachykinin-1, PPT, Substance P, Neurokinin A, Neuromedin L, Substance K, Neuropeptide K, Neuropeptide gamma, C-terminal-flanking peptide).